The effect of cinobufacini injection on DNA topoisomerase I of human hepatocellular carcinoma HepG-2 cells
Xiaonan Cui
Abstract
Xiaonan Cui
Abstract
Background and purpose:The cinobufacini injection is a traditional antitumor drug.However,its mechanism is still unclear.The purpose of this study was to observe the effect of cinobufacini injections in DNA TOPOⅠ of human hepatocellular carcinoma HepG-2 cells.Methods:The cells that were proliferated were assessed by MTT assay.Cell cycles were shown through FCM.TOPOⅠmRNA expression was analyzed through RT-PCR.The activity of TOPOⅠ was measured by TOPOⅠ mediated super coiled PBR322 relaxation.Supercoiled PBR322 was also used to determine the direct DNA breakages.Results:Cinobufacini injections significantly inhibited HepG-2 cells proliferation in ways that were dependent on dosages and time.Induced tumor cells arrest at the S-phase.TOPOⅠ mRNA expression decreased in a manner that was dependent on dosages which inhibited the TOPOⅠ mediated DNA relaxations.However,the cinobufacini injections could not directly induce DNA breakage at any concentration.Conclusion:Cinobufacini injections can inhibit human hepatocellular carcinoma HepG-2 cells proliferation.The regulation of topoisomerase Ⅰ activity and mRNA expression may be one of the mechanisms that causes the cinobufacini injection to contribute against tumor.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background and purpose:The cinobufacini injection is a traditional antitumor drug.However,its mechanism is still unclear.The purpose of this study was to observe the effect of cinobufacini injections in DNA TOPOⅠ of human hepatocellular carcinoma HepG-2 cells.Methods:The cells that were proliferated were assessed by MTT assay.Cell cycles were shown through FCM.TOPOⅠmRNA expression was analyzed through RT-PCR.The activity of TOPOⅠ was measured by TOPOⅠ mediated super coiled PBR322 relaxation.Supercoiled PBR322 was also used to determine the direct DNA breakages.Results:Cinobufacini injections significantly inhibited HepG-2 cells proliferation in ways that were dependent on dosages and time.Induced tumor cells arrest at the S-phase.TOPOⅠ mRNA expression decreased in a manner that was dependent on dosages which inhibited the TOPOⅠ mediated DNA relaxations.However,the cinobufacini injections could not directly induce DNA breakage at any concentration.Conclusion:Cinobufacini injections can inhibit human hepatocellular carcinoma HepG-2 cells proliferation.The regulation of topoisomerase Ⅰ activity and mRNA expression may be one of the mechanisms that causes the cinobufacini injection to contribute against tumor.
Key concepts: Topoisomerase, Hepatocellular carcinoma, Molecular biology, DNA, Chemistry, MTT assay, Cell cycle, Messenger RNA